Ｍ－リボミック（4591）　RIBOMIC Announces Presentation of Masked Preliminary Interim Data from Phase 2 Trials of RBM-007 for Wet AMD at the Retina Society 2021 Meeting 2021/09/30
/-
読み込み中…